An organotypic in vitro model containing microtumor spheroids, macrophages, neutrophils, fibroblasts and endothelial cells, allowing for the analysis of tumor–stroma interactions, was established with 3-D Life Hydrogel. After 20 days of culture, spheroid growth, a fibroblast network and vascular sprouting was clearly visible, the latter likely to be induced by endogenous VEGF. Cultures were miniaturized on transwell 96-well plates and treated with the drug cisplatin showing a reduction of tumor spheroid size and the fibroblast network. Results suggest that the model is highly suitable as a testing platform for novel anticancer therapeutics targeting the tumor as well as the vascular compartment.Publications
Kuehlbach et al. (2021) Recapitulating the Angiogenic Switch in a Hydrogel-Based 3D In Vitro Tumor-Stroma Model. Bioengineering 8: 186 (Article) Applications
Drug screening, tumor-stroma model, cell-based therapeutic development, drug testing, cancer research
Methods
Fluorescence microscopy, drug screening, phase-contrast microscopy, culture in multiwell inserts
Cells
H838 (human non-small-cell lung carcinoma), HCT 116 (colon carcinoma, human), HUVECs (Human Umbilical Vein Endothelial Cells), HL-60 (human, differentiated to neutrophils), U937 (human lymphoblast), Human dermal fibroblasts
Products used
3-D Life RGD Peptide
3-D Life Dextran-CD Hydrogel SG
Please send a message to order products or if you would like to know more about Cellendes:
Cellendes GmbH
Gerhard-Kindler-Str. 8
D-72770 Reutlingen
Germany
Ph.: +49 7121 15940 0
Fax: +49 7121 15940 99
info@cellendes.com